OBJECTIVE: To review the most currently accepted treatment options for We t
reatment of listeriosis.
DATA SOURCES: Clinical literature was accessed through
MEDLINE (1996-October 1999). Key search terms included Listeria monocytogen
es, food-borne illness, penicillins, fluoroquinolones, cephalosporins, and
vancomycin.
DATA SYNTHESIS: Listeriosis is mainly a food-borne illness caused by L. mon
ocytogenes; People most prone to the disease are pregnant women, newborns,
elderly, and those with HIV or other diseases compromising immunity. Lister
ia injections are associated with a high mortality rate, and thus effective
antibiotic treatment is essential, Although a variety of antibiotics have
activity the organism; ampicillin alone or in combination with gentamicin r
emains the treatment of choice. Some patients may alternative therapies due
to allergies or certain disease states. Second-line agents for these cases
include trimethoprim/ sulfamethoxazole erythromycin, vancomycin, and the f
luoroquinolones. Cephalosporins are not active against Listeria.
CONCLUSIONS: Ampicillin is currently the drug of choice for treating L. mon
ocytogenes infections. Many antibiotics have been shown to be effective and
are used as second-line agents. However, further study is required for som
e of the most recently introduced such as the fluoroquinolones, to determin
e their place in the treatment of Listeria infections.